Description
FOXO4-DRI peptide is an investigational synthetic peptide widely studied for its potential role in cellular senescence and longevity research. Designed to disrupt the interaction between the FOXO4 and p53 proteins, FOXO4-DRI has become an important research peptide in studies focused on healthy aging, cellular biology, and age-related molecular mechanisms. FOXO4-DRI research continues to explore how selective targeting of senescent cells may influence tissue homeostasis, regenerative biology, and overall cellular function.
Current FOXO4-DRI peptide research has investigated its interaction with signaling pathways involved in cellular aging, apoptosis, and senescence. Numerous FOXO4-DRI studies have examined its potential effects on the survival of senescent cells and its biological activity in laboratory models of aging and regenerative science. Researchers continue to evaluate FOXO4-DRI to better understand its molecular mechanisms, pharmacological profile, and potential applications in longevity research, age-related cellular processes, and translational biomedical science.
As interest in senolytic compounds and healthy aging continues to expand, FOXO4-DRI peptide remains an important investigational compound across multiple areas of scientific research. Ongoing preclinical studies continue to improve the understanding of FOXO4-DRI, its interaction with the FOXO4-p53 pathway, and its potential role in advancing research related to cellular resilience, tissue regeneration, and longevity.
FOXO4-DRI is intended for laboratory and scientific research purposes only. This investigational research peptide is not approved for human consumption or therapeutic use.







Edward W. –
High-quality research material with consistent presentation from batch to batch. Used for wellness research applications.